Recombinant antibodies for cancer diagnosis and therapy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Expert Opinion on Biological Therapy

• Publication date

  2003-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14712598.3.2.305PMID 11728219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library

  2003cited by this paper
• Engineered antibodies

  2003cited by this paper
• A novel strategy by the action of ricin that connects phenotype and genotype without loss of the diversity of libraries.

  2002cited by this paper
• Epitope affinity chromatography and biophysical studies of monoclonal antibodies and recombinant antibody fragments.

  2002cited by this paper
• An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells

  2002cited by this paper
• The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancer

  2002cited by this paper
• Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T‐lymphocyte responses against a melanoma tumor antigen

  2002cited by this paper
• Phage versus phagemid libraries for generation of human monoclonal antibodies.

  2002cited by this paper
• A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized.

  2002cited by this paper
• Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody.

  2002cited by this paper
• Selection of antibodies against biotinylated antigens.

  2002cited by this paper
• The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells

  2002cited by this paper
• A carcinoembryonic antigen‐specific diabody produced in tobacco

  2002cited by this paper
• Increased sophistication of immunotoxins.

  2002cited by this paper
• Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice.

  2002cited by this paper
• Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.

  2002cited by this paper
• Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head‐and‐neck cancer xenografts

  2002cited by this paper
• Analysis of the binding of bispecific monoclonal antibodies with immobilized antigens (human IgG and horseradish peroxidase) using a resonant mirror biosensor.

  2002cited by this paper
• Polyethylene glycol in the design of tumor-targetting radiolabelled macromolecules -- lessons from liposomes and monoclonal antibodies.

  2002cited by this paper
• Synergistic Antitumor Effect of Bispecific CD19 × CD3 and CD19 × CD16 Diabodies in a Preclinical Model of Non-Hodgkin’s Lymphoma1

  2002cited by this paper
• Overview of antibody phage-display technology and its applications.

  2002cited by this paper
• Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour

  2002cited by this paper
• Pharmacokinetics and Brain Uptake of Biotinylated Basic Fibroblast Growth Factor Conjugated to a Blood-Brain Barrier Drug Delivery System

  2002cited by this paper
• In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications.

  2002cited by this paper
• A model‐based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection

  2002cited by this paper
• Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism Abolished

  2002cited by this paper
• Contrasting IgG structures reveal extreme asymmetry and flexibility.

  2002cited by this paper
• Selection of phage‐displayed llama single‐domain antibodies that transmigrate across human blood‐brain barrier endothelium

  2002cited by this paper
• A kinetic trap is an intrinsic feature in the folding pathway of single-chain Fv fragments.

  2002cited by this paper
• Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

  2002influential reference
• Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.

  2002cited by this paper
• Improved renal clearance and tumor targeting of 99mTc-labeled anti-Tac monoclonal antibody Fab by chemical modifications.

  2002cited by this paper
• Tumour biology: Herceptin acts as an anti-angiogenic cocktail

  2002cited by this paper
• Large-scale bacterial fermentation and isolation of scFv multimers using a heat-inducible bacterial expression vector.

  2002cited by this paper
• Soluble expression of a functional recombinant cytolytic immunotoxin in insect cells.

  2002cited by this paper
• T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.

  2002cited by this paper
• Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker.

  2002cited by this paper
• Inhibition of metalloproteinases enhances the internalization of anti‐CD30 antibody Ki‐3 and the cytotoxic activity of Ki‐3 immunotoxin

  2002cited by this paper
• In vitro selection for catalytic activity with ribosome display.

  2002cited by this paper
• Tumor cell-specific gene transfer with retroviral vectors displaying single-chain antibody.

  2002cited by this paper
• Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.

  2002cited by this paper
• The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies.

  2002cited by this paper
• Isolation of receptor–ligand pairs by capture of long-lived multivalent interaction complexes

  2002cited by this paper
• Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 x anti-CD3 bispecific diabody.

  2002cited by this paper
• Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices

  2002cited by this paper
• Copper-67 as a therapeutic nuclide for radioimmunotherapy

  2002cited by this paper
• Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study

  2002cited by this paper
• TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor

  2002cited by this paper
• A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells.

  2002cited by this paper
• Vascular-Targeted Radioimmunotherapy with the Alpha-Particle Emitter 211At

  2002cited by this paper
• The recombinant T cell receptor strategy: insights into structure and function of recombinant immunoreceptors on the way towards an optimal receptor design for cellular immunotherapy.

  2002cited by this paper
• A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma

  2002cited by this paper
• A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro.

  2002cited by this paper
• Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy.

  2002cited by this paper
• Targeted therapy of cancer with radiolabeled antibodies.

  2002cited by this paper
• Clinical Applications of Phage-Derived sFvs and sFv Fusion Proteins

  2002cited by this paper
• Structure-Function Relationships for Human Antibodies to Pneumococcal Capsular Polysaccharide from Transgenic Mice with Human Immunoglobulin Loci

  2002cited by this paper
• Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study

  2002cited by this paper
• Gene Therapy of Murine Solid Tumors with T Cells Transduced with a Retroviral Vascular Endothelial Growth Factor–Immunotoxin Target Gene

  2002cited by this paper
• Chain shuffling to modify properties of recombinant immunoglobulins.

  2002cited by this paper
• Tumor growth suppression by a retroviral vector displaying scFv antibody to CEA and carrying the iNOS gene.

  2002cited by this paper
• Self-immobilizing recombinant antibody fragments for immunoaffinity chromatography: generic, parallel, and scalable protein purification.

  2002cited by this paper
• Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.

  2002cited by this paper
• Use of Escherichia coli mutator cells to mature antibodies.

  2002cited by this paper
• Expression of scFvs and scFv fusion proteins in eukaryotic cells.

  2002cited by this paper
• Error-prone polymerase chain reaction for modification of scFvs.

  2002cited by this paper
• Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity

  2002cited by this paper
• Ribosome display for selection of active dihydrofolate reductase mutants using immobilized methotrexate on agarose beads

  2002cited by this paper
• Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.

  2002cited by this paper
• Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein

  2002cited by this paper
• Ligand binding of a ribosome-displayed protein detected in solution at the single molecule level by fluorescence correlation spectroscopy

  2002cited by this paper
• Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies.

  2002cited by this paper
• Autoantigen microarrays for multiplex characterization of autoantibody responses

  2002cited by this paper
• TCR-Like Human Antibodies Expressed on Human CTLs Mediate Antibody Affinity-Dependent Cytolytic Activity1

  2002cited by this paper
• Cloned transchromosomic calves producing human immunoglobulin

  2002cited by this paper
• Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains.

  2002cited by this paper
• Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.

  2002cited by this paper
• Redirecting adenovirus to pulmonary endothelium by cationic liposomes

  2002cited by this paper
• Towards proteome-wide production of monoclonal antibody by phage display.

  2002cited by this paper
• Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection.

  2002cited by this paper
• Antibody‐guided enzyme therapy of cancer producing cyanide results in necrosis of targeted cells

  2002cited by this paper
• Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies.

  2002cited by this paper
• Novel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.

  2002cited by this paper
• Binding to CD20 by Anti-B1 Antibody or F(ab')2 is sufficient for induction of apoptosis in B-cell lines

  2002cited by this paper
• Pharmacokinetic and tumor‐seeking properties of recombinant and nonrecombinant anti‐carcinoembryonic antigen antibody fragments

  2002cited by this paper
• Production and characterisation of a recombinant scFv reactive with human gastrointestinal carcinomas

  2002cited by this paper
• An update on epidermal growth factor receptor inhibitors

  2002cited by this paper
• Radioimmunotherapy of A431 xenografted mice with pretargeted B3 antibody-streptavidin and (90)Y-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-biotin.

  2002cited by this paper
• Therapeutic antibodies: Magic bullets hit the target

  2002cited by this paper
• Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein.

  2002cited by this paper
• Secretion of active anti-Ras single-chain Fv antibody by the yeasts Yarrowia lipolytica and Kluyveromyces lactis.

  2002cited by this paper
• Efficient Delivery of T Cell Epitopes to APC by Use of MHC Class II-Specific Troybodies1

  2002cited by this paper
• A central core structure in an antibody variable domain determines antigen specificity.

  2001cited by this paper
• Engineering and Characterization of a Novel Fusion Protein Incorporating B7.2 and an Anti–ErbB-2 Single-Chain Antibody Fragment for the Activation of Jurkat T Cells

  2001cited by this paper
• Numerical Selection of Optimal Tumor Imaging Agents with Application to Engineered Antibodies

  2001cited by this paper
• Anti-HLA-DR/anti-DOTA Diabody Construction in a Modular Gene Design Platform: Bispecific Antibodies for Pretargeted Radioimmunotherapy

  2001cited by this paper
• Expression of single-chain Fv-Fc fusions in Pichia pastoris.

  2001cited by this paper
• Improving the efficacy of antibody-based cancer therapies

  2001cited by this paper
• Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library.

  2001cited by this paper
• Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody.

  2001cited by this paper

• A PAS-targeting hERG1 activator reduces arrhythmic events in Jervell and Lange-Nielsen syndrome patient-derived hiPSC-CMs

  2025cites this paper
• Construction, expression, and characterization of scFv fragment against Fasciola gigantica cathepsin L1H

  2025cites this paper
• Production of functional recombinant antibodies in Dictyostelium discoideum

  2025cites this paper
• Recombinant antibody fragment therapeutics: Current status and future prospects of scFv, nanobody, and mimotopes

  2023cites this paper
• Therapeutic Antibodies in Medicine

  2023cites this paper
• Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer

  2021cites this paper
• Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies

  2020cites this paper
• Bacteriophages: cancer diagnosis, treatment, and future prospects

  2020cites this paper
• Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds

  2020cites this paper
• Novel insights into the role of aptamers in the fight against cancer

  2019cites this paper
• Potential for Tight Junction Protein–Directed Drug Development Using Claudin Binders and Angubindin-1

  2019cites this paper
• Production of scFv recombinant fragments against 2,4-dichlorophenoxyacetic acid hapten using naďve phage library

  2018cites this paper
• Generation of hapten-specific recombinant antibodies: antibody phage display technology: a review

  2018cites this paper
• Readout Concepts for Label-Free Biomolecule Detection with Advanced ISFET and Silicon Nanowire Biosensors

  2018cites this paper
• Gas-stimuli-responsive molecularly imprinted polymer particles with switchable affinity for target protein.

  2018cites this paper
• The Efficacy of Humanized Antibody against the Sporothrix Antigen, gp70, in Promoting Phagocytosis and Reducing Disease Burden

  2017cites this paper
• Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.

  2017cites this paper
• A novel cholesterol/lipid delivery system for murine myeloma cell lines

  2017cites this paper
• RIPL peptide as a novel cell-penetrating and homing peptide: design, characterization, and application to liposomal nanocarriers for hepsin-specific intracellular drug delivery

  2017cites this paper
• ACDS TO MAMMALIAN CELLSVIA

  2017cites this paper
• Derivative of Extremophilic 50S Ribosomal Protein L35Ae as an Alternative Protein Scaffold

  2017cites this paper
• Aptamers: versatile molecular recognition probes for cancer detection.

  2016cites this paper
• Kinetic analysis of a high-affinity antibody/antigen interaction performed by planar waveguide fluorescence immunosensor

  2016cites this paper
• Extremophilic 50S Ribosomal RNA-Binding Protein L35Ae as a Basis for Engineering of an Alternative Protein Scaffold

  2015cites this paper
• Hybrid Curcumin Compounds: A New Strategy for Cancer Treatment

  2014cites this paper
• Application of Green Fluorescent Protein in Immunoassays

  2014cites this paper
• RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells.

  2014cites this paper
• Monoclonal Antibodies: Therapeutic Uses

  2013cites this paper
• Force distribution on multiple bonds controls the kinetics of adhesion in stretched cells.

  2013cites this paper
• Cell-free systems: functional modules for synthetic and chemical biology.

  2013cites this paper
• Isolation of scFv antibody fragments against HER2 and CEA tumor antigens from combinatorial antibody libraries derived from cancer patients.

  2013cites this paper
• Expression of single-domain antibodies in bacterial systems.

  2012cites this paper
• Fluobodies against Bioactive Natural Products and their Application in Fluorescence-Linked Immunosorbent Assay

  2012cites this paper
• A Native Chemical Ligation Approach for Combinatorial Assembly of Affibody Molecules

  2012cites this paper
• Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting IL-13 Receptor alpha2

  2012cites this paper
• Erratum

  2012cites this paper
• Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor α2*

  2012cites this paper
• Bispecific Antibodies for Diagnostic Applications

  2011cites this paper
• Efficient method for production of high yields of Fab fragments in Drosophila S2 cells.

  2010cites this paper
• Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment

  2010cites this paper
• Development of sensitivity-improved fluorescence-linked immunosorbent assay using a fluorescent single-domain antibody against the bioactive naphthoquinone, plumbagin

  2010cites this paper
• Patent Evaluation Metalloproteinase binding proteins : WO 2009097397 Yoshifumi Itoh

  2010cites this paper
• Selection of full‐length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence‐activated cell sorting screening

  2010cites this paper
• Expression, purification, and characterization of recombinant fibulin-5 in a prokaryote expression system

  2010cites this paper
• Metalloproteinase binding proteins: WO2009097397

  2010cites this paper
• Séquences d'acides aminés améliorées dirigées contre le virus respiratoire syncytial (rsv) humain et polypeptides les comprenant pour la prévention et/ou le traitement des infections de l'appareil respiratoire

  2010cites this paper
• An expression system for the E. coli fermentation of recombinant antibody Fab fragments from mice and rabbits.

  2010cites this paper
• Construction of scFv phage display library with hapten-specific repertories and characterization of anti-ivermectin fragment isolated from the library

  2010cites this paper
• Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions.

  2010cites this paper
• Modeling the three-dimensional structures of an unbound single-chain variable fragment (scFv) and its hypothetical complex with a Corynespora cassiicola toxin, cassiicolin

  2010cites this paper
• Generation of recombinant antibodies and means for increasing their affinity

  2010cites this paper
• Tobacco, a highly efficient green bioreactor for production of therapeutic proteins

  2009cites this paper
• Intrabody and Parkinson's disease.

  2009cites this paper
• Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

  2009cites this paper
• Single‐Molecule Approach to Understanding Multivalent Binding Kinetics

  2009cites this paper
• Séquences d'acides aminés dirigées contre des protéines d'enveloppe d'un virus, et polypeptides comprenant ces séquences destinés au traitement de maladies virales

  2009cites this paper
• Des minicellules intactes dérivées par les bactéries englobant un acide nucléique fonctionnel exempt de plasmide pour l'administration in vivo à des cellules de mammifère

  2008cites this paper
• Lentivirus Display: Stable Expression of Human Antibodies on the Surface of Human Cells and Virus Particles

  2008cites this paper
• Hendra and Nipah Viruses: Lethal Zoonotic Paramyxoviruses

  2008cites this paper
• Specific targeting of hepatitis C virus core protein by an intracellular single‐chain antibody of human origin

  2008cites this paper
• The selection of single-chain Fv antibody fragments specific to Bhlp 29.7 protein of Brachyspira hyodysenteriae

  2008cites this paper
• Screening isolates from antibody phage-display libraries.

  2008cites this paper
• The production and application of single-chain antibody fragments

  2008cites this paper
• Preparation of Recombinant Viral Glycoproteins for Novel and Therapeutic Antibody Discovery

  2008cites this paper
• Counting and Breaking Single Bonds

  2008cites this paper
• Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses.

  2007cites this paper
• Nanobodies in therapeutic applications.

  2007cites this paper
• Administration ciblée de médicaments, d'acides nucléiques thérapeutiques et d'acides nucléiques fonctionnels à des cellules mammaliennes via des cellules bactériennes tuées

  2007cites this paper
• Targeted Strategies for Henipavirus Therapeutics

  2007cites this paper
• Affilin-novel binding molecules based on human γ-B-crystallin, an all β-sheet protein

  2007cites this paper
• Isolation of Lawsonia intracellularis specific single-chain Fv antibody fragments from phage display library.

  2007cites this paper
• Intracellularly selected recombinant antibodies targeting β Amyloid Oligomers

  2007cites this paper
• Cholesterol delivery to NS0 cells: challenges and solutions in disposable linear low-density polyethylene-based bioreactors.

  2007cites this paper
• Ribosome display for improved biotherapeutic molecules

  2006cites this paper
• Recombinant antibodies in cancer therapy.

  2006cites this paper
• Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting

  2006cites this paper
• Developments towards effective treatments for Nipah and Hendra virus infection

  2006cites this paper
• Expression and Characterization of a Recombinant Single-Domain Monoclonal Antibody Against MUC1 Mucin in Tobacco Plants

  2006cites this paper
• Receptor-Binding Sites

  2006cites this paper
• Production and characterization of recombinant human anti-HBs Fab antibodies.

  2005cites this paper
• Construction of human recombinant ScFv phage libraries from the advanced stages of breast carcinoma patients

  2005cites this paper
• Antibody-mediated targeting of human single-chain class I MHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes

  2005cites this paper
• In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase.

  2005cites this paper
• Tumor-directed lymphocyte-activating cytokines: refolding-based preparation of recombinant human interleukin-12 and an antibody variable domain-fused protein by additive-introduced stepwise dialysis.

  2005cites this paper
• Enhancement of the Therapeutic Index: From Nonmyeloablative and Myeloablative toward Pretargeted Radioimmunotherapy for Metastatic Prostate Cancer

  2005cites this paper
• Ligand recognition in SH3-mediated protein interactions

  2005cites this paper
• Cationization of monoclonal antibodies: another step towards the "magic bullet"?

  2005cites this paper
• AB0 Blood Group System

  2005cites this paper
• Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels

  2005cites this paper
• Utilizing a GnRH-based chimeric protein for the detection of adenocarcinoma.

  2005cites this paper
• Nanobodies as novel agents for cancer therapy

  2005cites this paper
• Radioimmunotherapy of non-Hodgkin’s lymphoma: a critical appraisal

  2005cites this paper
• Prokaryotic expression of antibodies

  2005cites this paper
• Paracrine Inhibition of Prion Propagation by Anti-PrP Single-Chain Fv Miniantibodies

  2005cites this paper
• Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity

  2005cites this paper
• Directed evolution of single-chain Fv for cytoplasmic expression using the β-galactosidase complementation assay results in proteins highly susceptible to protease degradation and aggregation

  2004cites this paper
• Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay.

  2004cites this paper
• Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1

  2004cites this paper
• Anticorps monoclonaux et thérapeutique

  2004cites this paper
• Isolation and Characterization of the Human Monoclonal Antibodies C10 in Single-Chain Fragment Variable (scFv) Format to Glucose Oxidase from Aspergillus niger

  2004cites this paper